Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 10/20 | 0.73 |
| ▸ | ALB | P02768 | 2/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | VKORC1 | Q9BQB6 | 2/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.70 |
| ▸ | PCSK7 | Q16549 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.56 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | BRD4 | O60885 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1479347 | 1.00 | CYP2C9 (0.73) | CYP2C9ALBHSD17B10ALDH1A1VKORC1 | |
| SCHEMBL20806 | 1.00 | CYP2C9 (0.73) | CYP2C9ALBHSD17B10ALDH1A1VKORC1 | |
| Phosphoric Acid SCHEMBL28278851 | 0.94 | CYP2C9 (0.66) | CYP2C9ALBHSD17B10ALDH1A1VKORC1 | |
| SCHEMBL1477912 | 0.92 | CYP2C9 (0.63) | CYP2C9ALBHSD17B10ALDH1A1VKORC1 | |
| SCHEMBL1478281 | 0.88 | CYP2C9 (0.58) | CYP2C9ALBHSD17B10ALDH1A1VKORC1 | |
| SCHEMBL29489752 | 0.88 | CYP2C9 (0.58) | CYP2C9ALBHSD17B10ALDH1A1VKORC1 | |
| SCHEMBL43382 | 0.88 | CYP2C9 (0.76) | CYP2C9ALBHSD17B10ALDH1A1VKORC1 | |
| SCHEMBL1477562 | 0.88 | CYP2C9 (0.76) | CYP2C9ALBHSD17B10ALDH1A1VKORC1 | |
| SCHEMBL513899 | 0.85 | CYP2C9 (0.55) | CYP2C9ALBHSD17B10ALDH1A1VKORC1 | |
| SCHEMBL1651720 | 0.85 | CYP2C9 (0.68) | CYP2C9ALBHSD17B10ALDH1A1VKORC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3578542-B1 | COMPOSITIONS HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-11-12 | — | — | EP | claimed |
| EP-3578543-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-08-20 | — | — | EP | claimed |
| EP-3578541-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY, AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-05-28 | — | — | EP | claimed |
| EP-3407717-B1 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2021-07-28 | — | — | EP | claimed |
| EP-3407716-B9 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2021-07-14 | — | — | EP | claimed |
| EP-3407720-B1 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2021-03-10 | — | — | EP | claimed |
| EP-3408263-B1 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2021-03-03 | — | — | EP | claimed |
| EP-3407716-B1 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2021-02-17 | — | — | EP | claimed |
| EP-3407718-B1 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2021-02-17 | — | — | EP | claimed |
| EP-3232788-B1 | TRIAZOLES DERIVATIVES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2019-06-12 | — | — | EP | claimed |
| CN-106415244-A | Reactive marker compounds and uses thereof | 中央研究院 | 2017-02-15 | — | — | CN | claimed |
| CN-101051364-A | Self adaptive flow method based on rule constrain in office automation | SHANDONG GENERAL SOFTWARE CO L (CN) | 2007-10-10 | — | — | CN | claimed |
| CN-1505619-A | Preparation of warfarin sodium from warfarin sodium 2-propanol clathrate by nondestructive solvent expulsion | ������ҩ������˾ | 2004-06-16 | — | — | CN | claimed |
| CN-1505620-A | Process for purification of warfarin acid, warfarin alkali metal salts and corresponding clathrates | ������ҩ������˾ | 2004-06-16 | — | — | CN | claimed |
| CN-1152869-A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | UNIV EMORY (US) | 1997-06-25 | — | — | CN | claimed |
| US-20260076363-A1 | Bait Composition | SCIMETRICS LIMITED CORP. (US) | 2026-03-19 | — | — | US | disclosed |
| US-12478062-B2 | Bait composition | SCIMETRICS LIMITED CORP. (US) | 2025-11-25 | — | — | US | disclosed |
| CN-1365274-A | Porous drug matrices and methods of making same | ACUSPHERE INC (US) | 2002-08-21 | — | — | CN | disclosed |
| CN-1263522-A | Compounds and methods for inhibiting VCAM-1 expression | ATHEROGENICS INC (US) | 2000-08-16 | — | — | CN | disclosed |
| CN-1152869-A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | UNIV EMORY (US) | 1997-06-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076363-A1 | Bait Composition | VKORC1, FH, VKORC1L1 | CYP2C9 21/4885ALB 3732/4885HSD17B10 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.